GRM5 and early-onset autosomal dominant Alzheimer disease: Dysregulation of mGluR5 signaling has been implicated in several neurological and psychiatric disorders, including Alzheimer's disease (AD), schizophrenia (SCZ), and fragile X syndrome [10, 11].